743 filings
Page 27 of 38
DEFA14A
KANT
Kineta, Inc.
7 May 18
Additional proxy soliciting materials
9:04am
EFFECT
KANT
Kineta, Inc.
26 Apr 18
Notice of effectiveness
12:00am
CORRESP
KANT
Kineta, Inc.
24 Apr 18
Correspondence with SEC
12:00am
8-K
KANT
Kineta, Inc.
23 Apr 18
Entry into a Material Definitive Agreement
12:00am
S-3/A
KANT
Kineta, Inc.
Shelf registration (amended)
19 Apr 18
12:00am
DEFA14A
KANT
Kineta, Inc.
19 Apr 18
Additional proxy soliciting materials
12:00am
DEF 14A
KANT
Kineta, Inc.
Definitive proxy
19 Apr 18
12:00am
8-K
KANT
Kineta, Inc.
17 Apr 18
Entry into a Material Definitive Agreement
12:00am
UPLOAD
KANT
Kineta, Inc.
12 Apr 18
Letter from SEC
12:00am
SC 13G
KANT
Kineta, Inc.
10 Apr 18
Proteostasis Therapeutics, Inc.
12:00am
S-3
KANT
Kineta, Inc.
Shelf registration
6 Apr 18
12:00am
8-K
KANT
Kineta, Inc.
4 Apr 18
Other Events
12:00am
424B5
KANT
Kineta, Inc.
26 Mar 18
Prospectus supplement for primary offering
12:00am
8-K
KANT
Kineta, Inc.
23 Mar 18
Entry into a Material Definitive Agreement
12:00am
424B5
KANT
Kineta, Inc.
23 Mar 18
Prospectus supplement for primary offering
12:00am
424B5
KANT
Kineta, Inc.
19 Mar 18
Prospectus supplement for primary offering
12:00am
S-8
KANT
Kineta, Inc.
15 Mar 18
Registration of securities for employees
12:00am
10-K
2017 FY
KANT
Kineta, Inc.
Annual report
14 Mar 18
12:00am
8-K
KANT
Kineta, Inc.
14 Mar 18
Results of Operations and Financial Condition
12:00am
8-K
KANT
Kineta, Inc.
13 Mar 18
Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy
12:00am